ARCHIVES

In Brief: Override Failure Would Leave Cancer Program With No Money or New Projects Of Any Kind

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

Abbott To Supply Quest With Immunoassay Tests.

September 29, 2000

FY 1990 Bypass Budget f $2.345 Billion Approved By NCAB; Hammer’s Effort Makes That Possible

May 20, 1988

NCI Cooperative Group, Cancer Center Trials Listed

September 26, 2008

Novel Four Drug Combination Safe For Lung Cancer Therapy

November 28, 2008

Von Eschenbach To Leave FDA Jan. 20, Says He Was “In Love” With The Agency.

December 19, 2008

Berlin, DeVita Differ On Use Of L-PAM

November 8, 1974